Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (921)	11/25/1997 11:21:00 PM
From: DR. BOND	Read Replies (1) \| Respond to of 7041

FYI..Zoners...Rumor has it tomorrow could be a good day for ZONA! I hear a rebuttal to Aresenio's piece is in the works. DB

To: Cacaito who wrote (921)	11/26/1997 8:30:00 AM
From: Zebra 365	Read Replies (1) \| Respond to of 7041

<<Experience with buccal phentolamine mesylate for impotence>> Given what was said in the conference call about acheiving rapid increases in blood levels, my thoughts went immediately to buccal administration, still an "oral" treatment. No matter what the carrier compound would be, any oral drug (to be swallowed) taken on a full stomach will experience some delay in absorption and a flattening of the blood level curve, and therefore a loss of efficacy. Any comments? Does anyone know for sure that Vasomax is NOT a buccal medication? Does anyone have the details on the "method-of-use" patent pending? Zebra